News

Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration (FDA) approval for use to close femoral veins. The MynxGrip device is now...

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral coronary angiography. The findings...

Hemostasis Biolife StatSeal Advanced Disc Cath Lab

Cath Labs, interventional radiology suites and hospitals are continually trying to improve patient comfort as well as save time and reduce costs. With these goals in mind, Biolife introduces...

Cardiva Medical Inc. Vascade Vascular Closure System Series 3 financing U.S.

Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital. The company will use...

Transluminal Technologies LLC CE mark velox CD Vascular Closure Device

Transluminal Technologies LLC, a Syracuse, NY-based medical device company, received CE mark approval for the velox CD Vascular Closure Device. 

Mynx Vascular Closure Device Cardinal Health 2 Millionth Shipment June 2014

Cardinal Health announced the 2 millionth shipment of the Mynx Vascular Closure Device (VCD).

Cardinal Health AccessClosure Acquisition Vascular Closure Devices Cath Lab

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million. 

AccessClosure Next-Generation Vascular Closure Device ACC.14 March 2014

AccessClosure Inc. commercially launched itsMynx Ace vascular closure device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system...

AccessClosure Mynx Ace Vascular Closure Device Hemostasis Management Cath Lab

AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical ...

Vascular Solutions ThrombiDisc Topical Hemostat Introducer Sheaths Cath Lab

Vascular Solutions Inc. launched the ThrombiDisc topical hemostat designed for use around...

hemostasis management cath lab safeguard medical systems datascope air-band

Merit Medical Systems Inc. announced that it has acquired Datascope Corp.’s Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure and...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

vascular closure device

Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus reducing patients’ stay in the hospital (shorter time to ambulation) as...

The U.S. Food and Drug Administration (FDA) accepted Biomedica’s Investigational New Drug (IND) application for ClotFoam, a novel hemostat for intraoperative hemorrhage. The company will now...

The U.S. District Court for the District of New Jersey approved an agreement under which Vascular Solutions Inc. will cease further manufacture, sales and distribution of its R-Band Radial...

Maquet Cardiovascular LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for its new Air-Band Radial Compression Device....

Guardian II Hemostais Valve, recall

The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC Hemostasis Valves. The firm is...

Terumo Medical Corp. announced it filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co. Ltd. in the U.S. District Court of New Jersey.

...

CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic...

Cardiva Medical FDA Pre Market Approval Vascade VCS

Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (VCS). Clinical data from a prospective...